Clinical Trial Results TV
Main Menu
Home Page
Member Area
Browse all videos
Series
Duke Clinical Medicine
Cath Lab
ACS
Endocrinology
Gastroenterology
Nephrology
Heart Failure
SCAI TV
Categories
Antiplatelets
Antithrombins
Aortic Disease
Behind The Science
Biomarkers
CABG
CHF
CT Angio
Cardiac MRI
Clinical Cases
Congenital
DVT / PE
Diabetes
ECG, EKG, Holter
ECHO
EP
ETT / Nuclear Imaging
Fellows' Training
Genetics
HTN
Health economics QOL
Hospital Administration
International
Lipid Lowering
Lower extremity Dz
Lytics
Non Atherosclerotic Arterial Dz
PAD
PCI / Devices
Pathophysiology
Patient Education
Pericardium
Private Practice
Public Health
Pulm. Art. HTN
ST Elevation MI
Stable Angina
Stem Cell Tx
Stroke
Trial / Study
UA / NSTEMI
Valvular Heart Dz
Vlogs
Womens' Health
Trial / Study: 1191 submissions (showing 1036 to 1050)
|
Page 1
|
Page 2
|
Page 3
|
Page 4
|
Page 5
|
Page 6
|
Page 7
|
Page 8
|
Page 9
|
Page 10
|
Page 11
|
Page 12
|
Page 13
|
Page 14
|
Page 15
|
Page 16
|
Page 17
|
Page 18
|
Page 19
|
Page 20
|
Page 21
|
Page 22
|
Page 23
|
Page 24
|
Page 25
|
Page 26
|
Page 27
|
Page 28
|
Page 29
|
Page 30
|
Page 31
|
Page 32
|
Page 33
|
Page 34
|
Page 35
|
Page 36
|
Page 37
|
Page 38
|
Page 39
|
Page 40
|
Page 41
|
Page 42
|
Page 43
|
Page 44
|
Page 45
|
Page 46
|
Page 47
|
Page 48
|
Page 49
|
Page 50
|
Page 51
|
Page 52
|
Page 53
|
Page 54
|
Page 55
|
Page 56
|
Page 57
|
Page 58
|
Page 59
|
Page 60
|
Page 61
|
Page 62
|
Page 63
|
Page 64
|
Page 65
|
Page 66
|
Page 67
|
Page 68
|
Page 69
|
Page 70
|
Page 71
|
Page 72
|
Page 73
|
Page 74
|
Page 75
|
Page 76
|
Page 77
|
Page 78
|
Page 79
|
Page 80
|
Dr. Christopher Cannon and Dr. C. Michael Gibson discuss the PCI findings of the PLATO trial
Dr. Christopher P. Cannon, Dr. C. Michael Gibson, MD
Dr. Cannon and Dr. Gibson discuss the COGENT Trial and the limitations of observational data
Dr. Christopher P. Cannon, Dr. C. Michael Gibson, MD
Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the results of the COGENT Trial
Dr. Deepak Bhatt, Dr. C. Michael Gibson, MD
Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the results of the CHARISMA Genomics Substudy
Dr. Deepak Bhatt, Dr. C. Michael Gibson, MD
Dr. David Cohen and Dr. C. Michael Gibson discuss the TRITON-TIMI 38 Economic Substudy
Dr. David Cohen, MD, Dr. C. Michael Gibson, MD
Dr. Junbo Ge and Dr. C. Michael Gibson discuss the results of the NO REFLOW Trial
Dr. C. Michael Gibson, MD, Dr. Ge Junbo
Dr. Sanjay Kaul and Dr. C. Michael Gibson discuss the findings of the PLATO trial
Dr. Sanjay Kaul, Dr. C. Michael Gibson, MD
Dr. Flavio Ribichini and Dr. C. Michael Gibson discuss the results of the CEREA-DES Trial
Dr. C. Michael Gibson, MD, Dr. Flavio Ribichini
Dr. Josef Veselka and Dr. C. Michael Gibson discuss the STATINS PRE-PCI Trial
Dr. C. Michael Gibson, MD
Dr. Robert Byrne and Dr. C. Michael Gibson discuss the ISAR-DESIRE 2 Trial
Dr. Robert Byrne, Dr. C. Michael Gibson
Dr. Stephan Windecker and Dr. C. Michael Gibson discuss the results of the SIRTAX-LATE Trial from TCT 2009
Dr. C. Michael Gibson, MD
Dr. William Fearon and Dr. C. Michael Gibson discuss the 2-year results of the FAME Study from TCT 2009
Dr. C. Michael Gibson, , Dr. William Fearon
Dr. Harrington and Dr. Gibson discuss the role of CRP in cardiovascular disease
Dr. Robert Harrington, Dr. C. Michael Gibson, MD
Drs. Harrington and Gibson discuss the clinical implications of vulnerable plaque and arterial wall remodeling on CTA
Dr. Robert Harrington, MD, Dr. C. Michael Gibson
Drs. Harrington and Gibson discuss the BARI 2D trial, factor 10a inhibitors, and the need for more sensitive bleeding me
Dr. Robert Harrington, MD, Dr. C. Michael Gibson, MD
clinicaltrialresults.org
